We overpaid for Meda. Mylan will be laying off everyone in the US Meda AB and closing the Somerset location in order to try and make some money back. This was a horrible decision to purchase.
Jeffrey Loo, an analyst at S&P Global Market Intelligence, said investors have been concerned that Mylan was paying too much for Meda, a company that is generating lower sales and profit. In the first half of this year, Meda posted a 4 percent drop in revenue and a 5 percent decline in income.
“That was part of the justification for paying such a sizeable premium,” he said. “It's one of those things where we have to wait and see how it does for Mylan.”